Stryker Corporation (SYK) Scheduled to Post Quarterly Earnings on Thursday

Stryker Corporation (NYSE:SYK) is scheduled to announce its earnings results after the market closes on Thursday, October 26th. Analysts expect the company to announce earnings of $1.52 per share for the quarter. Stryker Corporation has set its Q3 guidance at $1.50-1.55 EPS and its FY17 guidance at $6.45-6.55 EPS.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. During the same quarter in the previous year, the company earned $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts expect Stryker Corporation to post $6.45 EPS for the current fiscal year and $7.09 EPS for the next fiscal year.

Stryker Corporation (NYSE SYK) opened at 148.64 on Thursday. The company’s 50 day moving average is $143.70 and its 200-day moving average is $140.89. The stock has a market cap of $55.60 billion, a PE ratio of 33.18 and a beta of 0.80. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $150.00.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is presently 37.95%.

A number of brokerages recently issued reports on SYK. Zacks Investment Research downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. BidaskClub downgraded shares of Stryker Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Cowen and Company set a $160.00 price target on shares of Stryker Corporation and gave the stock a “buy” rating in a report on Friday, October 6th. Oppenheimer Holdings, Inc. set a $148.00 price target on shares of Stryker Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $132.00 price target on shares of Stryker Corporation in a report on Friday, June 30th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. Stryker Corporation currently has a consensus rating of “Hold” and an average price target of $146.78.

ILLEGAL ACTIVITY WARNING: This report was first posted by Week Herald and is the property of of Week Herald. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://weekherald.com/2017/10/19/stryker-corporation-syk-scheduled-to-post-quarterly-earnings-on-thursday.html.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares in the company, valued at $12,909,976.52. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The disclosure for this sale can be found here. Company insiders own 7.40% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Earnings History for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply